OpenAlex
PricingAboutJobs
Log inGet started
Work

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

HTML PDF

Year: 2018
Type: article
Source: Journal of the American College of Cardiology
DOI: 10.1016/j.jacc.2018.03.490
Authors: Paul M Ridker, Jean G. MacFadyen, Robert J. Glynn, Wolfgang Koenig, Peter Libby, Brendan M. Everett, Martin Lefkowitz, Tom Thuren, Jan H. Cornel
Institutions: Brigham and Women's Hospital, Harvard University, Universität Ulm, German Centre for Cardiovascular Research, Deutsches Herzzentrum München, Technical University of Munich, Novartis (Switzerland), Noordwest Ziekenhuisgroep
Language: English

Topic: Inflammasome and immune disorders
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: canakinumab, IL-1β inhibition, chronic kidney disease, major adverse cardiovascular events, NLRP3 inflammasome, high-sensitivity C-reactive protein, post-infarction patients, atherosclerosis, renal function, albuminuria, inflammation, kidney disease, cardiovascular mortality, stroke, myocardial infarction, diabetes mellitus
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2803976987
FWCI: 7.414
Cites: 30
Cited by: 344
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms